OBJECTIVE: Fetal cell free DNA (cfDNA) in the maternal circulation is thought to be primarily of placental origin. We sought to determine if fetuses with a low fetal fraction (FF) in the first trimester are more likely to be affected by placental-mediated conditions, primarily low birth weight. STUDY DESIGN: This is a retrospective cohort study of women who had negative cfDNA screening <14 weeks gestation and delivered a viable infant between July 2016 and June 2018 at a single institution. Women with a multiple gestation or abnormal cfDNA screen were excluded. Women who had a non-reportable cfDNA result were included if their re-draw was negative. FF5%ile were considered to have a low FF. The primary outcome was birth weight 10%ile using growth curves generated by Oken et al. Secondary outcomes included birth weight 5%ile, abruption, hypertensive disorder of pregnancy, stillbirth, and a composite outcome. Chi-squared tests were used for comparisons. Multivariable logistic regressions calculated odds ratios for the primary and secondary outcomes, adjusting for maternal age, BMI, gestational age at draw, parity, chronic hypertension, and tobacco use. RESULTS: Of the 2034 women included, the mean FF was 10.0% (SD 3.4%) and a FF<5.3% was considered low (n¼101). For all women, 66.4% had cfDNA testing at 12 weeks gestation, the median BMI was 24.0 (IQR 21.6-27.5), 42.3% were nulliparous, 1.8% had a diagnosis of chronic hypertension, and 0.7% used tobacco. Compared to pregnancies with a higher FF, there was no significant difference in the incidence of birth weight 10%ile in women with a low FF (11.9 vs 8.0%, p¼0.17), though the comparison was limited by small sample size. Among secondary outcomes, birth weight 5%ile and the composite outcome were significantly higher in the low FF group. In the multivariable analysis, low FF was associated with an increased odds of birth weight 10%ile [aOR 2.20 (95%CI 1.12-4.30)], birth weight £5%ile [aOR 3.23 (95%CI 1.35-7.74)], and the composite adverse outcome [aOR 1.91 (95%CI 1.10-3.33)]. CONCLUSION: Low FF (5%ile) among women with negative cfDNA results in the first trimester is associated with increased odds of low birth weight, similar to women with a low PAPP-A. Future studies are needed to determine if a low FF should prompt screening for growth restriction given the potential implications of this recommendation.
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The accuracy of targeted-SGA fetal weight estimation e results from the multicentre PORTO study (2017) formulae. The accuracy of the formulae was assessed using percentage error when compared to birthweight. A prediction model was also used to account for potential fetal growth during the interval to delivery. RESULTS: Complete fetal biometry within one week of delivery (median of 3 days) was available in 588 pregnancies recruited with an EFW < 10 th centile. The mean birthweight at delivery was 2,311g (SD¼647g) and the median gestational age at delivery was 37.7 weeks (range¼26.4-42.6 weeks).
Boxplots of percentage error are presented in figure 1 . The Hadlock III, IV and Sabbagha III formulae were similar in having almost no systematic bias (median percentage error < 1%). All three formulae had similar random errors (inter-quartiles ranges 10-13%) and had the highest proportion of estimated fetal weights within 10% of birthweight (77%). Percentage error was dependent upon both gestational age at scan (p<0.001) and time interval to delivery (p<0.001). Results using projection to delivery methods improved the accuracy of the other formulae but did not change the conclusions (Table 1) .
A retrospective analysis restricting to those with birthweight < 10 th centile (n¼442) found similar results. A sub-analysis in those with abnormal umbilical artery Doppler (n¼303) also found similar results. CONCLUSION: Our study, which recruited pregnancies with suspected SGA (EFW < 10 th centile using the Hadlock IV formula), suggests that there is no benefit to subsequently switching to formulae that is targeted for the SGA fetus or low birthweight infant. 
OBJECTIVE:
The optimal management of monochorionic diamniotic twins complicated by SIUGR Type II is unknown. The aim of this study was to identify predictors of survival of the SIUGR twin after undergoing selective laser photocoagulation of communicating vessels (laser). STUDY DESIGN: All patients undergoing laser for SIUGR Type II from 2006 to 2018 at our center were retrospectively studied. SIUGR Type II was defined as an estimated fetal weight <10 th percentile (Hadlock) with persistent absent and/or reversed end diastolic flow in the umbilical artery of the SIUGR twin, in the absence of twin-twin transfusion syndrome. Patient, preoperative ultrasound, and operative characteristics associated with 30-day survival of the SIUGR twin were compared using bivariate analysis and multiple logistic regression models. For the purposes of this study, normal middle cerebral artery (MCA) peak systolic velocity (psv) was defined as less than 1.5 multiples of the median (MoM), and normal ductus venosus (DV) waveform was defined as the absence of reversed atrial systolic flow. 
